|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:MYO1C-YWHAE (FusionGDB2 ID:56300) |
Fusion Gene Summary for MYO1C-YWHAE |
Fusion gene summary |
Fusion gene information | Fusion gene name: MYO1C-YWHAE | Fusion gene ID: 56300 | Hgene | Tgene | Gene symbol | MYO1C | YWHAE | Gene ID | 4643 | 7531 |
Gene name | myosin IE | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon | |
Synonyms | FSGS6|HuncM-IC|MYO1C | 14-3-3E|HEL2|KCIP-1|MDCR|MDS | |
Cytomap | 15q22.2 | 17p13.3 | |
Type of gene | protein-coding | protein-coding | |
Description | unconventional myosin-IeMYO1E variant proteinmyosin-ICunconventional myosin 1E | 14-3-3 protein epsilon14-3-3 epsilonepididymis luminal protein 2mitochondrial import stimulation factor L subunitprotein kinase C inhibitor protein-1tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptidetyrosine | |
Modification date | 20200313 | 20200327 | |
UniProtAcc | . | P62258 | |
Ensembl transtripts involved in fusion gene | ENST00000359786, ENST00000438665, ENST00000575158, ENST00000361007, ENST00000545534, ENST00000573198, | ENST00000264335, ENST00000571732, ENST00000573026, ENST00000575977, ENST00000498643, | |
Fusion gene scores | * DoF score | 6 X 8 X 5=240 | 25 X 13 X 12=3900 |
# samples | 7 | 32 | |
** MAII score | log2(7/240*10)=-1.77760757866355 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(32/3900*10)=-3.60733031374961 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: MYO1C [Title/Abstract] AND YWHAE [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | YWHAE(1303340)-MYO1C(1387597), # samples:2 MYO1C(1385772)-YWHAE(1248793), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | MYO1C-YWHAE seems lost the major protein functional domain in Hgene partner, which is a epigenetic factor due to the frame-shifted ORF. MYO1C-YWHAE seems lost the major protein functional domain in Tgene partner, which is a CGC due to the frame-shifted ORF. MYO1C-YWHAE seems lost the major protein functional domain in Tgene partner, which is a epigenetic factor due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | YWHAE | GO:0000165 | MAPK cascade | 12917326 |
Tgene | YWHAE | GO:0034605 | cellular response to heat | 12917326 |
Tgene | YWHAE | GO:0046827 | positive regulation of protein export from nucleus | 12917326 |
Tgene | YWHAE | GO:0051480 | regulation of cytosolic calcium ion concentration | 18029012 |
Tgene | YWHAE | GO:0060306 | regulation of membrane repolarization | 11953308 |
Tgene | YWHAE | GO:1901016 | regulation of potassium ion transmembrane transporter activity | 11953308 |
Tgene | YWHAE | GO:1901020 | negative regulation of calcium ion transmembrane transporter activity | 18029012 |
Tgene | YWHAE | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation | 11953308 |
Tgene | YWHAE | GO:1905913 | negative regulation of calcium ion export across plasma membrane | 18029012 |
Fusion gene breakpoints across MYO1C (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across YWHAE (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | LUSC | TCGA-94-8491 | MYO1C | chr17 | 1385772 | - | YWHAE | chr17 | 1248793 | - |
Top |
Fusion Gene ORF analysis for MYO1C-YWHAE |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Frame-shift | ENST00000359786 | ENST00000264335 | MYO1C | chr17 | 1385772 | - | YWHAE | chr17 | 1248793 | - |
In-frame | ENST00000359786 | ENST00000571732 | MYO1C | chr17 | 1385772 | - | YWHAE | chr17 | 1248793 | - |
In-frame | ENST00000359786 | ENST00000573026 | MYO1C | chr17 | 1385772 | - | YWHAE | chr17 | 1248793 | - |
Frame-shift | ENST00000359786 | ENST00000575977 | MYO1C | chr17 | 1385772 | - | YWHAE | chr17 | 1248793 | - |
5CDS-intron | ENST00000359786 | ENST00000498643 | MYO1C | chr17 | 1385772 | - | YWHAE | chr17 | 1248793 | - |
Frame-shift | ENST00000438665 | ENST00000264335 | MYO1C | chr17 | 1385772 | - | YWHAE | chr17 | 1248793 | - |
In-frame | ENST00000438665 | ENST00000571732 | MYO1C | chr17 | 1385772 | - | YWHAE | chr17 | 1248793 | - |
In-frame | ENST00000438665 | ENST00000573026 | MYO1C | chr17 | 1385772 | - | YWHAE | chr17 | 1248793 | - |
Frame-shift | ENST00000438665 | ENST00000575977 | MYO1C | chr17 | 1385772 | - | YWHAE | chr17 | 1248793 | - |
5CDS-intron | ENST00000438665 | ENST00000498643 | MYO1C | chr17 | 1385772 | - | YWHAE | chr17 | 1248793 | - |
In-frame | ENST00000575158 | ENST00000264335 | MYO1C | chr17 | 1385772 | - | YWHAE | chr17 | 1248793 | - |
Frame-shift | ENST00000575158 | ENST00000571732 | MYO1C | chr17 | 1385772 | - | YWHAE | chr17 | 1248793 | - |
Frame-shift | ENST00000575158 | ENST00000573026 | MYO1C | chr17 | 1385772 | - | YWHAE | chr17 | 1248793 | - |
Frame-shift | ENST00000575158 | ENST00000575977 | MYO1C | chr17 | 1385772 | - | YWHAE | chr17 | 1248793 | - |
5CDS-intron | ENST00000575158 | ENST00000498643 | MYO1C | chr17 | 1385772 | - | YWHAE | chr17 | 1248793 | - |
Frame-shift | ENST00000361007 | ENST00000264335 | MYO1C | chr17 | 1385772 | - | YWHAE | chr17 | 1248793 | - |
In-frame | ENST00000361007 | ENST00000571732 | MYO1C | chr17 | 1385772 | - | YWHAE | chr17 | 1248793 | - |
In-frame | ENST00000361007 | ENST00000573026 | MYO1C | chr17 | 1385772 | - | YWHAE | chr17 | 1248793 | - |
Frame-shift | ENST00000361007 | ENST00000575977 | MYO1C | chr17 | 1385772 | - | YWHAE | chr17 | 1248793 | - |
5CDS-intron | ENST00000361007 | ENST00000498643 | MYO1C | chr17 | 1385772 | - | YWHAE | chr17 | 1248793 | - |
Frame-shift | ENST00000545534 | ENST00000264335 | MYO1C | chr17 | 1385772 | - | YWHAE | chr17 | 1248793 | - |
In-frame | ENST00000545534 | ENST00000571732 | MYO1C | chr17 | 1385772 | - | YWHAE | chr17 | 1248793 | - |
In-frame | ENST00000545534 | ENST00000573026 | MYO1C | chr17 | 1385772 | - | YWHAE | chr17 | 1248793 | - |
Frame-shift | ENST00000545534 | ENST00000575977 | MYO1C | chr17 | 1385772 | - | YWHAE | chr17 | 1248793 | - |
5CDS-intron | ENST00000545534 | ENST00000498643 | MYO1C | chr17 | 1385772 | - | YWHAE | chr17 | 1248793 | - |
intron-3CDS | ENST00000573198 | ENST00000264335 | MYO1C | chr17 | 1385772 | - | YWHAE | chr17 | 1248793 | - |
intron-3CDS | ENST00000573198 | ENST00000571732 | MYO1C | chr17 | 1385772 | - | YWHAE | chr17 | 1248793 | - |
intron-3CDS | ENST00000573198 | ENST00000573026 | MYO1C | chr17 | 1385772 | - | YWHAE | chr17 | 1248793 | - |
intron-3CDS | ENST00000573198 | ENST00000575977 | MYO1C | chr17 | 1385772 | - | YWHAE | chr17 | 1248793 | - |
intron-intron | ENST00000573198 | ENST00000498643 | MYO1C | chr17 | 1385772 | - | YWHAE | chr17 | 1248793 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000359786 | MYO1C | chr17 | 1385772 | - | ENST00000571732 | YWHAE | chr17 | 1248793 | - | 1912 | 952 | 277 | 1011 | 244 |
ENST00000359786 | MYO1C | chr17 | 1385772 | - | ENST00000573026 | YWHAE | chr17 | 1248793 | - | 1597 | 952 | 277 | 1011 | 244 |
ENST00000438665 | MYO1C | chr17 | 1385772 | - | ENST00000571732 | YWHAE | chr17 | 1248793 | - | 1753 | 793 | 40 | 852 | 270 |
ENST00000438665 | MYO1C | chr17 | 1385772 | - | ENST00000573026 | YWHAE | chr17 | 1248793 | - | 1438 | 793 | 40 | 852 | 270 |
ENST00000575158 | MYO1C | chr17 | 1385772 | - | ENST00000264335 | YWHAE | chr17 | 1248793 | - | 1927 | 699 | 150 | 758 | 202 |
ENST00000361007 | MYO1C | chr17 | 1385772 | - | ENST00000571732 | YWHAE | chr17 | 1248793 | - | 1591 | 631 | 82 | 690 | 202 |
ENST00000361007 | MYO1C | chr17 | 1385772 | - | ENST00000573026 | YWHAE | chr17 | 1248793 | - | 1276 | 631 | 82 | 690 | 202 |
ENST00000545534 | MYO1C | chr17 | 1385772 | - | ENST00000571732 | YWHAE | chr17 | 1248793 | - | 1758 | 798 | 635 | 0 | 212 |
ENST00000545534 | MYO1C | chr17 | 1385772 | - | ENST00000573026 | YWHAE | chr17 | 1248793 | - | 1443 | 798 | 635 | 0 | 212 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000359786 | ENST00000571732 | MYO1C | chr17 | 1385772 | - | YWHAE | chr17 | 1248793 | - | 0.004766665 | 0.99523336 |
ENST00000359786 | ENST00000573026 | MYO1C | chr17 | 1385772 | - | YWHAE | chr17 | 1248793 | - | 0.005644271 | 0.9943558 |
ENST00000438665 | ENST00000571732 | MYO1C | chr17 | 1385772 | - | YWHAE | chr17 | 1248793 | - | 0.006610412 | 0.9933896 |
ENST00000438665 | ENST00000573026 | MYO1C | chr17 | 1385772 | - | YWHAE | chr17 | 1248793 | - | 0.008996917 | 0.99100304 |
ENST00000575158 | ENST00000264335 | MYO1C | chr17 | 1385772 | - | YWHAE | chr17 | 1248793 | - | 0.004939773 | 0.99506015 |
ENST00000361007 | ENST00000571732 | MYO1C | chr17 | 1385772 | - | YWHAE | chr17 | 1248793 | - | 0.00551925 | 0.9944807 |
ENST00000361007 | ENST00000573026 | MYO1C | chr17 | 1385772 | - | YWHAE | chr17 | 1248793 | - | 0.007361737 | 0.99263823 |
ENST00000545534 | ENST00000571732 | MYO1C | chr17 | 1385772 | - | YWHAE | chr17 | 1248793 | - | 0.002894404 | 0.99710554 |
ENST00000545534 | ENST00000573026 | MYO1C | chr17 | 1385772 | - | YWHAE | chr17 | 1248793 | - | 0.00376057 | 0.9962394 |
Top |
Fusion Genomic Features for MYO1C-YWHAE |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for MYO1C-YWHAE |
Go to FGviewer for the breakpoints of chr17:1385772-chr17:1248793 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | YWHAE |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: Adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways. Binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif. Binding generally results in the modulation of the activity of the binding partner (By similarity). Positively regulates phosphorylated protein HSF1 nuclear export to the cytoplasm (PubMed:12917326). {ECO:0000250|UniProtKB:P62261, ECO:0000269|PubMed:12917326}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | MYO1C | chr17:1385772 | chr17:1248793 | ENST00000359786 | - | 5 | 32 | 139_148 | 209.0 | 1064.0 | Nucleotide binding | Note=ATP |
Hgene | MYO1C | chr17:1385772 | chr17:1248793 | ENST00000359786 | - | 5 | 32 | 192_196 | 209.0 | 1064.0 | Nucleotide binding | Note=ATP |
Hgene | MYO1C | chr17:1385772 | chr17:1248793 | ENST00000361007 | - | 5 | 32 | 139_148 | 174.0 | 1029.0 | Nucleotide binding | Note=ATP |
Hgene | MYO1C | chr17:1385772 | chr17:1248793 | ENST00000438665 | - | 5 | 32 | 139_148 | 190.0 | 1045.0 | Nucleotide binding | Note=ATP |
Hgene | MYO1C | chr17:1385772 | chr17:1248793 | ENST00000575158 | - | 5 | 32 | 139_148 | 174.0 | 1029.0 | Nucleotide binding | Note=ATP |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | MYO1C | chr17:1385772 | chr17:1248793 | ENST00000359786 | - | 5 | 32 | 47_731 | 209.0 | 1064.0 | Domain | Myosin motor |
Hgene | MYO1C | chr17:1385772 | chr17:1248793 | ENST00000359786 | - | 5 | 32 | 734_757 | 209.0 | 1064.0 | Domain | IQ 1 |
Hgene | MYO1C | chr17:1385772 | chr17:1248793 | ENST00000359786 | - | 5 | 32 | 758_786 | 209.0 | 1064.0 | Domain | IQ 2 |
Hgene | MYO1C | chr17:1385772 | chr17:1248793 | ENST00000359786 | - | 5 | 32 | 885_1059 | 209.0 | 1064.0 | Domain | TH1 |
Hgene | MYO1C | chr17:1385772 | chr17:1248793 | ENST00000361007 | - | 5 | 32 | 47_731 | 174.0 | 1029.0 | Domain | Myosin motor |
Hgene | MYO1C | chr17:1385772 | chr17:1248793 | ENST00000361007 | - | 5 | 32 | 734_757 | 174.0 | 1029.0 | Domain | IQ 1 |
Hgene | MYO1C | chr17:1385772 | chr17:1248793 | ENST00000361007 | - | 5 | 32 | 758_786 | 174.0 | 1029.0 | Domain | IQ 2 |
Hgene | MYO1C | chr17:1385772 | chr17:1248793 | ENST00000361007 | - | 5 | 32 | 885_1059 | 174.0 | 1029.0 | Domain | TH1 |
Hgene | MYO1C | chr17:1385772 | chr17:1248793 | ENST00000438665 | - | 5 | 32 | 47_731 | 190.0 | 1045.0 | Domain | Myosin motor |
Hgene | MYO1C | chr17:1385772 | chr17:1248793 | ENST00000438665 | - | 5 | 32 | 734_757 | 190.0 | 1045.0 | Domain | IQ 1 |
Hgene | MYO1C | chr17:1385772 | chr17:1248793 | ENST00000438665 | - | 5 | 32 | 758_786 | 190.0 | 1045.0 | Domain | IQ 2 |
Hgene | MYO1C | chr17:1385772 | chr17:1248793 | ENST00000438665 | - | 5 | 32 | 885_1059 | 190.0 | 1045.0 | Domain | TH1 |
Hgene | MYO1C | chr17:1385772 | chr17:1248793 | ENST00000575158 | - | 5 | 32 | 47_731 | 174.0 | 1029.0 | Domain | Myosin motor |
Hgene | MYO1C | chr17:1385772 | chr17:1248793 | ENST00000575158 | - | 5 | 32 | 734_757 | 174.0 | 1029.0 | Domain | IQ 1 |
Hgene | MYO1C | chr17:1385772 | chr17:1248793 | ENST00000575158 | - | 5 | 32 | 758_786 | 174.0 | 1029.0 | Domain | IQ 2 |
Hgene | MYO1C | chr17:1385772 | chr17:1248793 | ENST00000575158 | - | 5 | 32 | 885_1059 | 174.0 | 1029.0 | Domain | TH1 |
Hgene | MYO1C | chr17:1385772 | chr17:1248793 | ENST00000361007 | - | 5 | 32 | 192_196 | 174.0 | 1029.0 | Nucleotide binding | Note=ATP |
Hgene | MYO1C | chr17:1385772 | chr17:1248793 | ENST00000438665 | - | 5 | 32 | 192_196 | 190.0 | 1045.0 | Nucleotide binding | Note=ATP |
Hgene | MYO1C | chr17:1385772 | chr17:1248793 | ENST00000575158 | - | 5 | 32 | 192_196 | 174.0 | 1029.0 | Nucleotide binding | Note=ATP |
Hgene | MYO1C | chr17:1385772 | chr17:1248793 | ENST00000359786 | - | 5 | 32 | 608_630 | 209.0 | 1064.0 | Region | Actin-binding |
Hgene | MYO1C | chr17:1385772 | chr17:1248793 | ENST00000361007 | - | 5 | 32 | 608_630 | 174.0 | 1029.0 | Region | Actin-binding |
Hgene | MYO1C | chr17:1385772 | chr17:1248793 | ENST00000438665 | - | 5 | 32 | 608_630 | 190.0 | 1045.0 | Region | Actin-binding |
Hgene | MYO1C | chr17:1385772 | chr17:1248793 | ENST00000575158 | - | 5 | 32 | 608_630 | 174.0 | 1029.0 | Region | Actin-binding |
Top |
Fusion Gene Sequence for MYO1C-YWHAE |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000359786_ENST00000571732_TCGA-94-8491_MYO1C_chr17_1385772_-_YWHAE_chr17_1248793_length(transcript)=1912nt_BP=952nt GGAGCCCAGGGTCCCCCATGGGTGGCTGCATCGGCTCCTCTGGTTACCTGGGACAACAGGCATTTCCTCCATCCCCAGCCCCTCCTCTTC CTGCTCCAACCATCCGGGCCAAGAGGCCTCCCAGTCAGACCTGGACGGCTCCAGCCGTGTCCTGAGGAGCTGGACCAGCCACATCCCCTG GGGCTGCAGTTGAAGCAGAACCAAGTGGCCATCCCGGCGTTAGACCGTAGGTTCCTGGTCCCGGAGTGGTCGGAGCCCGCCAGTGGGCAG GCAGCTCTTGCTCACAGGCCGCGGTGCCCAGGCCGCTGGCTCTCCGCAGGGCGGAATGGCGCTGCAAGTGGAGCTGGTACCCACCGGGGA GATCATCCGCGTGGTTCATCCCCACAGGCCCTGCAAGCTTGCCCTGGGCAGTGACGGGGTTCGGGTGACCATGGAGAGTGCGCTCACCGC CCGTGACCGGGTGGGGGTGCAGGATTTCGTGCTGCTGGAGAACTTCACCAGCGAGGCCGCCTTCATCGAGAACCTGCGGCGGCGATTTCG GGAGAATCTCATCTACACCTACATTGGCCCCGTCCTGGTCTCTGTCAATCCCTACCGGGACCTGCAGATCTACAGCCGGCAGCATATGGA GCGTTACCGTGGCGTCAGCTTCTATGAAGTGCCCCCTCACCTGTTTGCCGTGGCGGACACTGTGTACCGAGCACTGCGCACGGAGCGTCG GGACCAGGCTGTGATGATCTCTGGGGAGAGCGGGGCAGGCAAGACCGAGGCCACCAAGAGGCTGCTGCAGTTCTATGCAGAGACCTGCCC AGCCCCCGAGCGCGGAGGTGCCGTGCGGGACCGGCTGCTACAGAGCAACCCGGTGCTGGAGGCCTTTGGAAATGCCAAGACCCTCCGGAA CGATAACTCCAGCAGGTTCGGGAAGTACATGGATGTGCAGTTTGACTTCAAGGTGAAGAGCAGAATAAAGAAGCGCTGCAGGACGTGGAA GACGAAAATCAGTGAGACATAAGCCAACAAGAGAAACCATCTCTGACCACCCCCTCCTCCCCATCCCACCCTTTGGAAACTCCCCATTGT CACTGAGAACCACCAAATCTGACTTTTACATTTGGTCTCAGAATTTAGGTTCCTGCCCTGTTGGTTTTTTTTTTTTTTTTTTAAACAGTT TTCAAAAGTTCTTAAAGGCAAGAGTGAATTTCTGTGGATTTTACTGGTCCCAGCTTTTAGGTTCTTTAAGACACTAACAGGACTACATAG AGGCTTTTTCAGCATTACTGTGTCGTCTCCGTGCCAGATGTGGCAAGATCACCATTAGCAAATGGAAATTACATTTGAAAGCCATTAGAC TTATAGGTGATGCAAGCATCTAAGAGAGAGGTTAATCACACTATAGAGGCATAAGTGGTATCAGTTTTCATTTTTCTAATTGTTTAAACT GTGTTTTATACCAGTGTTTGCAAGTAATTGGGTGTTAGCTTGAGATGGTTAAAGGTGGTTTGGGGAGGGACTTCGTTGTAATGGTTTTGC TGTAAAAAATGTTTCCAACTCCGCTGAAATGTTGCTGAAAAGCATGGTGCTGGTAACAGTTCAACAATCCGTGGCTGCTCATTCTTGCCT ACTTTACTCTCCCACTGAAGCAGGTTAGCGTTGAAGGTGGTATGGAAAAGCCTGCATGCCTGTTCAATTCTTTTGTTTCTTCTCCTTCCC CCTCCCCCTACCTCCTTCCCCTCACTCCTCCCCTCCTTCGCTCGCTCAACCTCTTTTGTTCAGTATGTGTAACTTGAAGCTAATTTGTAC TACTGGATATCTGACTGGAGCCACAGATACAGAATCTGTATTGTTCTTACTGAAACACAGCATGGAATTAACATTAAACTTAAATAAAAC >In-frame_ENST00000359786_ENST00000571732_TCGA-94-8491_MYO1C_chr17_1385772_-_YWHAE_chr17_1248793_length(amino acids)=244AA_start in transcript=277_stop in transcript=1011 MLTGRGAQAAGSPQGGMALQVELVPTGEIIRVVHPHRPCKLALGSDGVRVTMESALTARDRVGVQDFVLLENFTSEAAFIENLRRRFREN LIYTYIGPVLVSVNPYRDLQIYSRQHMERYRGVSFYEVPPHLFAVADTVYRALRTERRDQAVMISGESGAGKTEATKRLLQFYAETCPAP -------------------------------------------------------------- >In-frame_ENST00000359786_ENST00000573026_TCGA-94-8491_MYO1C_chr17_1385772_-_YWHAE_chr17_1248793_length(transcript)=1597nt_BP=952nt GGAGCCCAGGGTCCCCCATGGGTGGCTGCATCGGCTCCTCTGGTTACCTGGGACAACAGGCATTTCCTCCATCCCCAGCCCCTCCTCTTC CTGCTCCAACCATCCGGGCCAAGAGGCCTCCCAGTCAGACCTGGACGGCTCCAGCCGTGTCCTGAGGAGCTGGACCAGCCACATCCCCTG GGGCTGCAGTTGAAGCAGAACCAAGTGGCCATCCCGGCGTTAGACCGTAGGTTCCTGGTCCCGGAGTGGTCGGAGCCCGCCAGTGGGCAG GCAGCTCTTGCTCACAGGCCGCGGTGCCCAGGCCGCTGGCTCTCCGCAGGGCGGAATGGCGCTGCAAGTGGAGCTGGTACCCACCGGGGA GATCATCCGCGTGGTTCATCCCCACAGGCCCTGCAAGCTTGCCCTGGGCAGTGACGGGGTTCGGGTGACCATGGAGAGTGCGCTCACCGC CCGTGACCGGGTGGGGGTGCAGGATTTCGTGCTGCTGGAGAACTTCACCAGCGAGGCCGCCTTCATCGAGAACCTGCGGCGGCGATTTCG GGAGAATCTCATCTACACCTACATTGGCCCCGTCCTGGTCTCTGTCAATCCCTACCGGGACCTGCAGATCTACAGCCGGCAGCATATGGA GCGTTACCGTGGCGTCAGCTTCTATGAAGTGCCCCCTCACCTGTTTGCCGTGGCGGACACTGTGTACCGAGCACTGCGCACGGAGCGTCG GGACCAGGCTGTGATGATCTCTGGGGAGAGCGGGGCAGGCAAGACCGAGGCCACCAAGAGGCTGCTGCAGTTCTATGCAGAGACCTGCCC AGCCCCCGAGCGCGGAGGTGCCGTGCGGGACCGGCTGCTACAGAGCAACCCGGTGCTGGAGGCCTTTGGAAATGCCAAGACCCTCCGGAA CGATAACTCCAGCAGGTTCGGGAAGTACATGGATGTGCAGTTTGACTTCAAGGTGAAGAGCAGAATAAAGAAGCGCTGCAGGACGTGGAA GACGAAAATCAGTGAGACATAAGCCAACAAGAGAAACCATCTCTGACCACCCCCTCCTCCCCATCCCACCCTTTGGAAACTCCCCATTGT CACTGAGAACCACCAAATCTGACTTTTACATTTGGTCTCAGAATTTAGGTTCCTGCCCTGTTGGTTTTTTTTTTTTTTTTTTAAACAGTT TTCAAAAGTTCTTAAAGGCAAGAGTGAATTTCTGTGGATTTTACTGGTCCCAGCTTTTAGGTTCTTTAAGACACTAACAGGACTACATAG AGGCTTTTTCAGCATTACTGTGTCGTCTCCGTGCCAGATGTGGCAAGATCACCATTAGCAAATGGAAATTACATTTGAAAGCCATTAGAC TTATAGGTGATGCAAGCATCTAAGAGAGAGGTTAATCACACTATAGAGGCATAAGTGGTATCAGTTTTCATTTTTCTAATTGTTTAAACT GTGTTTTATACCAGTGTTTGCAAGTAATTGGGTGTTAGCTTGAGATGGTTAAAGGTGGTTTGGGGAGGGACTTCGTTGTAATGGTTTTGC >In-frame_ENST00000359786_ENST00000573026_TCGA-94-8491_MYO1C_chr17_1385772_-_YWHAE_chr17_1248793_length(amino acids)=244AA_start in transcript=277_stop in transcript=1011 MLTGRGAQAAGSPQGGMALQVELVPTGEIIRVVHPHRPCKLALGSDGVRVTMESALTARDRVGVQDFVLLENFTSEAAFIENLRRRFREN LIYTYIGPVLVSVNPYRDLQIYSRQHMERYRGVSFYEVPPHLFAVADTVYRALRTERRDQAVMISGESGAGKTEATKRLLQFYAETCPAP -------------------------------------------------------------- >In-frame_ENST00000438665_ENST00000571732_TCGA-94-8491_MYO1C_chr17_1385772_-_YWHAE_chr17_1248793_length(transcript)=1753nt_BP=793nt GGACCCCCCGCCCCGACACCCCCACCTCCACCAACCCCACCTGGAGGGGACCCCAGCCCGGCCGCGCGGGAGGCGGGGGAGGCCGGGGAA GCCCCGCGCTTCAGGGGCCCGGGTGGGGGCGGTGCGGGGGGCGGGCCCTCCCTCGCTGACGCCGCCGCCACCGCCGCCGAGCCCGGGACC CGGAGCGCGGGCAGCGGAGCGGGCGCCAGGCCGGCCGGGCAGGATGCGCTACCGGGCGTCGGCCCTGGGCAGTGACGGGGTTCGGGTGAC CATGGAGAGTGCGCTCACCGCCCGTGACCGGGTGGGGGTGCAGGATTTCGTGCTGCTGGAGAACTTCACCAGCGAGGCCGCCTTCATCGA GAACCTGCGGCGGCGATTTCGGGAGAATCTCATCTACACCTACATTGGCCCCGTCCTGGTCTCTGTCAATCCCTACCGGGACCTGCAGAT CTACAGCCGGCAGCATATGGAGCGTTACCGTGGCGTCAGCTTCTATGAAGTGCCCCCTCACCTGTTTGCCGTGGCGGACACTGTGTACCG AGCACTGCGCACGGAGCGTCGGGACCAGGCTGTGATGATCTCTGGGGAGAGCGGGGCAGGCAAGACCGAGGCCACCAAGAGGCTGCTGCA GTTCTATGCAGAGACCTGCCCAGCCCCCGAGCGCGGAGGTGCCGTGCGGGACCGGCTGCTACAGAGCAACCCGGTGCTGGAGGCCTTTGG AAATGCCAAGACCCTCCGGAACGATAACTCCAGCAGGTTCGGGAAGTACATGGATGTGCAGTTTGACTTCAAGGTGAAGAGCAGAATAAA GAAGCGCTGCAGGACGTGGAAGACGAAAATCAGTGAGACATAAGCCAACAAGAGAAACCATCTCTGACCACCCCCTCCTCCCCATCCCAC CCTTTGGAAACTCCCCATTGTCACTGAGAACCACCAAATCTGACTTTTACATTTGGTCTCAGAATTTAGGTTCCTGCCCTGTTGGTTTTT TTTTTTTTTTTTTAAACAGTTTTCAAAAGTTCTTAAAGGCAAGAGTGAATTTCTGTGGATTTTACTGGTCCCAGCTTTTAGGTTCTTTAA GACACTAACAGGACTACATAGAGGCTTTTTCAGCATTACTGTGTCGTCTCCGTGCCAGATGTGGCAAGATCACCATTAGCAAATGGAAAT TACATTTGAAAGCCATTAGACTTATAGGTGATGCAAGCATCTAAGAGAGAGGTTAATCACACTATAGAGGCATAAGTGGTATCAGTTTTC ATTTTTCTAATTGTTTAAACTGTGTTTTATACCAGTGTTTGCAAGTAATTGGGTGTTAGCTTGAGATGGTTAAAGGTGGTTTGGGGAGGG ACTTCGTTGTAATGGTTTTGCTGTAAAAAATGTTTCCAACTCCGCTGAAATGTTGCTGAAAAGCATGGTGCTGGTAACAGTTCAACAATC CGTGGCTGCTCATTCTTGCCTACTTTACTCTCCCACTGAAGCAGGTTAGCGTTGAAGGTGGTATGGAAAAGCCTGCATGCCTGTTCAATT CTTTTGTTTCTTCTCCTTCCCCCTCCCCCTACCTCCTTCCCCTCACTCCTCCCCTCCTTCGCTCGCTCAACCTCTTTTGTTCAGTATGTG TAACTTGAAGCTAATTTGTACTACTGGATATCTGACTGGAGCCACAGATACAGAATCTGTATTGTTCTTACTGAAACACAGCATGGAATT >In-frame_ENST00000438665_ENST00000571732_TCGA-94-8491_MYO1C_chr17_1385772_-_YWHAE_chr17_1248793_length(amino acids)=270AA_start in transcript=40_stop in transcript=852 MEGTPARPRGRRGRPGKPRASGARVGAVRGAGPPSLTPPPPPPSPGPGARAAERAPGRPGRMRYRASALGSDGVRVTMESALTARDRVGV QDFVLLENFTSEAAFIENLRRRFRENLIYTYIGPVLVSVNPYRDLQIYSRQHMERYRGVSFYEVPPHLFAVADTVYRALRTERRDQAVMI SGESGAGKTEATKRLLQFYAETCPAPERGGAVRDRLLQSNPVLEAFGNAKTLRNDNSSRFGKYMDVQFDFKVKSRIKKRCRTWKTKISET -------------------------------------------------------------- >In-frame_ENST00000438665_ENST00000573026_TCGA-94-8491_MYO1C_chr17_1385772_-_YWHAE_chr17_1248793_length(transcript)=1438nt_BP=793nt GGACCCCCCGCCCCGACACCCCCACCTCCACCAACCCCACCTGGAGGGGACCCCAGCCCGGCCGCGCGGGAGGCGGGGGAGGCCGGGGAA GCCCCGCGCTTCAGGGGCCCGGGTGGGGGCGGTGCGGGGGGCGGGCCCTCCCTCGCTGACGCCGCCGCCACCGCCGCCGAGCCCGGGACC CGGAGCGCGGGCAGCGGAGCGGGCGCCAGGCCGGCCGGGCAGGATGCGCTACCGGGCGTCGGCCCTGGGCAGTGACGGGGTTCGGGTGAC CATGGAGAGTGCGCTCACCGCCCGTGACCGGGTGGGGGTGCAGGATTTCGTGCTGCTGGAGAACTTCACCAGCGAGGCCGCCTTCATCGA GAACCTGCGGCGGCGATTTCGGGAGAATCTCATCTACACCTACATTGGCCCCGTCCTGGTCTCTGTCAATCCCTACCGGGACCTGCAGAT CTACAGCCGGCAGCATATGGAGCGTTACCGTGGCGTCAGCTTCTATGAAGTGCCCCCTCACCTGTTTGCCGTGGCGGACACTGTGTACCG AGCACTGCGCACGGAGCGTCGGGACCAGGCTGTGATGATCTCTGGGGAGAGCGGGGCAGGCAAGACCGAGGCCACCAAGAGGCTGCTGCA GTTCTATGCAGAGACCTGCCCAGCCCCCGAGCGCGGAGGTGCCGTGCGGGACCGGCTGCTACAGAGCAACCCGGTGCTGGAGGCCTTTGG AAATGCCAAGACCCTCCGGAACGATAACTCCAGCAGGTTCGGGAAGTACATGGATGTGCAGTTTGACTTCAAGGTGAAGAGCAGAATAAA GAAGCGCTGCAGGACGTGGAAGACGAAAATCAGTGAGACATAAGCCAACAAGAGAAACCATCTCTGACCACCCCCTCCTCCCCATCCCAC CCTTTGGAAACTCCCCATTGTCACTGAGAACCACCAAATCTGACTTTTACATTTGGTCTCAGAATTTAGGTTCCTGCCCTGTTGGTTTTT TTTTTTTTTTTTTAAACAGTTTTCAAAAGTTCTTAAAGGCAAGAGTGAATTTCTGTGGATTTTACTGGTCCCAGCTTTTAGGTTCTTTAA GACACTAACAGGACTACATAGAGGCTTTTTCAGCATTACTGTGTCGTCTCCGTGCCAGATGTGGCAAGATCACCATTAGCAAATGGAAAT TACATTTGAAAGCCATTAGACTTATAGGTGATGCAAGCATCTAAGAGAGAGGTTAATCACACTATAGAGGCATAAGTGGTATCAGTTTTC ATTTTTCTAATTGTTTAAACTGTGTTTTATACCAGTGTTTGCAAGTAATTGGGTGTTAGCTTGAGATGGTTAAAGGTGGTTTGGGGAGGG >In-frame_ENST00000438665_ENST00000573026_TCGA-94-8491_MYO1C_chr17_1385772_-_YWHAE_chr17_1248793_length(amino acids)=270AA_start in transcript=40_stop in transcript=852 MEGTPARPRGRRGRPGKPRASGARVGAVRGAGPPSLTPPPPPPSPGPGARAAERAPGRPGRMRYRASALGSDGVRVTMESALTARDRVGV QDFVLLENFTSEAAFIENLRRRFRENLIYTYIGPVLVSVNPYRDLQIYSRQHMERYRGVSFYEVPPHLFAVADTVYRALRTERRDQAVMI SGESGAGKTEATKRLLQFYAETCPAPERGGAVRDRLLQSNPVLEAFGNAKTLRNDNSSRFGKYMDVQFDFKVKSRIKKRCRTWKTKISET -------------------------------------------------------------- >In-frame_ENST00000575158_ENST00000264335_TCGA-94-8491_MYO1C_chr17_1385772_-_YWHAE_chr17_1248793_length(transcript)=1927nt_BP=699nt GTATTTGGACATTGGTTCTATTTTTAACTTTCCCGGGACTCGAGTTCGGGGGTTGGGGGAGGAAAATCCCGCTTCCTCTGGGACCCGCAG GCCTCGGTGCCCGCCCAGCGCCCAGGCCCGCCGCGGAGTGTAGTCCCAGGCCCGGAAGCCCTGGGCAGTGACGGGGTTCGGGTGACCATG GAGAGTGCGCTCACCGCCCGTGACCGGGTGGGGGTGCAGGATTTCGTGCTGCTGGAGAACTTCACCAGCGAGGCCGCCTTCATCGAGAAC CTGCGGCGGCGATTTCGGGAGAATCTCATCTACACCTACATTGGCCCCGTCCTGGTCTCTGTCAATCCCTACCGGGACCTGCAGATCTAC AGCCGGCAGCATATGGAGCGTTACCGTGGCGTCAGCTTCTATGAAGTGCCCCCTCACCTGTTTGCCGTGGCGGACACTGTGTACCGAGCA CTGCGCACGGAGCGTCGGGACCAGGCTGTGATGATCTCTGGGGAGAGCGGGGCAGGCAAGACCGAGGCCACCAAGAGGCTGCTGCAGTTC TATGCAGAGACCTGCCCAGCCCCCGAGCGCGGAGGTGCCGTGCGGGACCGGCTGCTACAGAGCAACCCGGTGCTGGAGGCCTTTGGAAAT GCCAAGACCCTCCGGAACGATAACTCCAGCAGGTTCGGGAAGTACATGGATGTGCAGTTTGACTTCAAGGTGAAGAGCAGAATAAAGAAG CGCTGCAGGACGTGGAAGACGAAAATCAGTGAGACATAAGCCAACAAGAGAAACCATCTCTGACCACCCCCTCCTCCCCATCCCACCCTT TGGAAACTCCCCATTGTCACTGAGAACCACCAAATCTGACTTTTACATTTGGTCTCAGAATTTAGGTTCCTGCCCTGTTGGTTTTTTTTT TTTTTTTTTAAACAGTTTTCAAAAGTTCTTAAAGGCAAGAGTGAATTTCTGTGGATTTTACTGGTCCCAGCTTTTAGGTTCTTTAAGACA CTAACAGGACTACATAGAGGCTTTTTCAGCATTACTGTGTCGTCTCCGTGCCAGATGTGGCAAGATCACCATTAGCAAATGGAAATTACA TTTGAAAGCCATTAGACTTATAGGTGATGCAAGCATCTAAGAGAGAGGTTAATCACACTATAGAGGCATAAGTGGTATCAGTTTTCATTT TTCTAATTGTTTAAACTGTGTTTTATACCAGTGTTTGCAAGTAATTGGGTGTTAGCTTGAGATGGTTAAAGGTGGTTTGGGGAGGGACTT CGTTGTAATGGTTTTGCTGTAAAAAATGTTTCCAACTCCGCTGAAATGTTGCTGAAAAGCATGGTGCTGGTAACAGTTCAACAATCCGTG GCTGCTCATTCTTGCCTACTTTACTCTCCCACTGAAGCAGGTTAGCGTTGAAGGTGGTATGGAAAAGCCTGCATGCCTGTTCAATTCTTT TGTTTCTTCTCCTTCCCCCTCCCCCTACCTCCTTCCCCTCACTCCTCCCCTCCTTCGCTCGCTCAACCTCTTTTGTTCAGTATGTGTAAC TTGAAGCTAATTTGTACTACTGGATATCTGACTGGAGCCACAGATACAGAATCTGTATTGTTCTTACTGAAACACAGCATGGAATTAACA TTAAACTTAAATAAAACAAACCTAAATTAAAAATGCCAAATATCGCGCCTCCATCCTTTATACTTCTAAAATAAAATCTCTAGTCCAAAC ACACTGACAGTATTATGTTTGCCTGAATGTGAAACATTCCTCCTTTTTTCTTCCATAAATAATTTGTTTGCTTCCCAAAGATGTATGTTT TGGAAAAAAATTGCCTGTAGTCTGGTTGTGAAGAACACTGAGTCAGTTGATGGTGTGTCTTGTCCTCCAGACCAGGCAGCAACATGGTAT >In-frame_ENST00000575158_ENST00000264335_TCGA-94-8491_MYO1C_chr17_1385772_-_YWHAE_chr17_1248793_length(amino acids)=202AA_start in transcript=150_stop in transcript=758 MGSDGVRVTMESALTARDRVGVQDFVLLENFTSEAAFIENLRRRFRENLIYTYIGPVLVSVNPYRDLQIYSRQHMERYRGVSFYEVPPHL FAVADTVYRALRTERRDQAVMISGESGAGKTEATKRLLQFYAETCPAPERGGAVRDRLLQSNPVLEAFGNAKTLRNDNSSRFGKYMDVQF -------------------------------------------------------------- >In-frame_ENST00000361007_ENST00000571732_TCGA-94-8491_MYO1C_chr17_1385772_-_YWHAE_chr17_1248793_length(transcript)=1591nt_BP=631nt AGAGTGCGCCCGGGCCGCGGATCCCCAAGCCCGCCACGCCGCCCAGCCCGGCCCCGCCCGCGCCGGAAGAGCCACGCCGGCCCTGGGCAG TGACGGGGTTCGGGTGACCATGGAGAGTGCGCTCACCGCCCGTGACCGGGTGGGGGTGCAGGATTTCGTGCTGCTGGAGAACTTCACCAG CGAGGCCGCCTTCATCGAGAACCTGCGGCGGCGATTTCGGGAGAATCTCATCTACACCTACATTGGCCCCGTCCTGGTCTCTGTCAATCC CTACCGGGACCTGCAGATCTACAGCCGGCAGCATATGGAGCGTTACCGTGGCGTCAGCTTCTATGAAGTGCCCCCTCACCTGTTTGCCGT GGCGGACACTGTGTACCGAGCACTGCGCACGGAGCGTCGGGACCAGGCTGTGATGATCTCTGGGGAGAGCGGGGCAGGCAAGACCGAGGC CACCAAGAGGCTGCTGCAGTTCTATGCAGAGACCTGCCCAGCCCCCGAGCGCGGAGGTGCCGTGCGGGACCGGCTGCTACAGAGCAACCC GGTGCTGGAGGCCTTTGGAAATGCCAAGACCCTCCGGAACGATAACTCCAGCAGGTTCGGGAAGTACATGGATGTGCAGTTTGACTTCAA GGTGAAGAGCAGAATAAAGAAGCGCTGCAGGACGTGGAAGACGAAAATCAGTGAGACATAAGCCAACAAGAGAAACCATCTCTGACCACC CCCTCCTCCCCATCCCACCCTTTGGAAACTCCCCATTGTCACTGAGAACCACCAAATCTGACTTTTACATTTGGTCTCAGAATTTAGGTT CCTGCCCTGTTGGTTTTTTTTTTTTTTTTTTAAACAGTTTTCAAAAGTTCTTAAAGGCAAGAGTGAATTTCTGTGGATTTTACTGGTCCC AGCTTTTAGGTTCTTTAAGACACTAACAGGACTACATAGAGGCTTTTTCAGCATTACTGTGTCGTCTCCGTGCCAGATGTGGCAAGATCA CCATTAGCAAATGGAAATTACATTTGAAAGCCATTAGACTTATAGGTGATGCAAGCATCTAAGAGAGAGGTTAATCACACTATAGAGGCA TAAGTGGTATCAGTTTTCATTTTTCTAATTGTTTAAACTGTGTTTTATACCAGTGTTTGCAAGTAATTGGGTGTTAGCTTGAGATGGTTA AAGGTGGTTTGGGGAGGGACTTCGTTGTAATGGTTTTGCTGTAAAAAATGTTTCCAACTCCGCTGAAATGTTGCTGAAAAGCATGGTGCT GGTAACAGTTCAACAATCCGTGGCTGCTCATTCTTGCCTACTTTACTCTCCCACTGAAGCAGGTTAGCGTTGAAGGTGGTATGGAAAAGC CTGCATGCCTGTTCAATTCTTTTGTTTCTTCTCCTTCCCCCTCCCCCTACCTCCTTCCCCTCACTCCTCCCCTCCTTCGCTCGCTCAACC TCTTTTGTTCAGTATGTGTAACTTGAAGCTAATTTGTACTACTGGATATCTGACTGGAGCCACAGATACAGAATCTGTATTGTTCTTACT >In-frame_ENST00000361007_ENST00000571732_TCGA-94-8491_MYO1C_chr17_1385772_-_YWHAE_chr17_1248793_length(amino acids)=202AA_start in transcript=82_stop in transcript=690 MGSDGVRVTMESALTARDRVGVQDFVLLENFTSEAAFIENLRRRFRENLIYTYIGPVLVSVNPYRDLQIYSRQHMERYRGVSFYEVPPHL FAVADTVYRALRTERRDQAVMISGESGAGKTEATKRLLQFYAETCPAPERGGAVRDRLLQSNPVLEAFGNAKTLRNDNSSRFGKYMDVQF -------------------------------------------------------------- >In-frame_ENST00000361007_ENST00000573026_TCGA-94-8491_MYO1C_chr17_1385772_-_YWHAE_chr17_1248793_length(transcript)=1276nt_BP=631nt AGAGTGCGCCCGGGCCGCGGATCCCCAAGCCCGCCACGCCGCCCAGCCCGGCCCCGCCCGCGCCGGAAGAGCCACGCCGGCCCTGGGCAG TGACGGGGTTCGGGTGACCATGGAGAGTGCGCTCACCGCCCGTGACCGGGTGGGGGTGCAGGATTTCGTGCTGCTGGAGAACTTCACCAG CGAGGCCGCCTTCATCGAGAACCTGCGGCGGCGATTTCGGGAGAATCTCATCTACACCTACATTGGCCCCGTCCTGGTCTCTGTCAATCC CTACCGGGACCTGCAGATCTACAGCCGGCAGCATATGGAGCGTTACCGTGGCGTCAGCTTCTATGAAGTGCCCCCTCACCTGTTTGCCGT GGCGGACACTGTGTACCGAGCACTGCGCACGGAGCGTCGGGACCAGGCTGTGATGATCTCTGGGGAGAGCGGGGCAGGCAAGACCGAGGC CACCAAGAGGCTGCTGCAGTTCTATGCAGAGACCTGCCCAGCCCCCGAGCGCGGAGGTGCCGTGCGGGACCGGCTGCTACAGAGCAACCC GGTGCTGGAGGCCTTTGGAAATGCCAAGACCCTCCGGAACGATAACTCCAGCAGGTTCGGGAAGTACATGGATGTGCAGTTTGACTTCAA GGTGAAGAGCAGAATAAAGAAGCGCTGCAGGACGTGGAAGACGAAAATCAGTGAGACATAAGCCAACAAGAGAAACCATCTCTGACCACC CCCTCCTCCCCATCCCACCCTTTGGAAACTCCCCATTGTCACTGAGAACCACCAAATCTGACTTTTACATTTGGTCTCAGAATTTAGGTT CCTGCCCTGTTGGTTTTTTTTTTTTTTTTTTAAACAGTTTTCAAAAGTTCTTAAAGGCAAGAGTGAATTTCTGTGGATTTTACTGGTCCC AGCTTTTAGGTTCTTTAAGACACTAACAGGACTACATAGAGGCTTTTTCAGCATTACTGTGTCGTCTCCGTGCCAGATGTGGCAAGATCA CCATTAGCAAATGGAAATTACATTTGAAAGCCATTAGACTTATAGGTGATGCAAGCATCTAAGAGAGAGGTTAATCACACTATAGAGGCA TAAGTGGTATCAGTTTTCATTTTTCTAATTGTTTAAACTGTGTTTTATACCAGTGTTTGCAAGTAATTGGGTGTTAGCTTGAGATGGTTA AAGGTGGTTTGGGGAGGGACTTCGTTGTAATGGTTTTGCTGTAAAAAATGTTTCCAACTCCGCTGAAATGTTGCTGAAAAGCATGGTGCT >In-frame_ENST00000361007_ENST00000573026_TCGA-94-8491_MYO1C_chr17_1385772_-_YWHAE_chr17_1248793_length(amino acids)=202AA_start in transcript=82_stop in transcript=690 MGSDGVRVTMESALTARDRVGVQDFVLLENFTSEAAFIENLRRRFRENLIYTYIGPVLVSVNPYRDLQIYSRQHMERYRGVSFYEVPPHL FAVADTVYRALRTERRDQAVMISGESGAGKTEATKRLLQFYAETCPAPERGGAVRDRLLQSNPVLEAFGNAKTLRNDNSSRFGKYMDVQF -------------------------------------------------------------- >In-frame_ENST00000545534_ENST00000571732_TCGA-94-8491_MYO1C_chr17_1385772_-_YWHAE_chr17_1248793_length(transcript)=1758nt_BP=798nt GCCCCCGGCCAGAAATCTGGGCCTTTCGTGGTCAGAGGACACCGGCGGCCCCTTTGGGATCCACCCCCAATCACCACCACCTTGTTCTTC TCTGACCCTGGATACTCTGGGTGTCCATTTTTTGGAGCCCTGAGACCCTGTTTGAAGAGGGATCCATCTCAGCCCTGGTTGTGGGGCGAG GGTCTTGCTCAGCCTGCACCACCCTCCACCCTCCAGTAGGACCCAGAGGCAGCTGGGCTTTCCATGGCCCTGGGCAGTGACGGGGTTCGG GTGACCATGGAGAGTGCGCTCACCGCCCGTGACCGGGTGGGGGTGCAGGATTTCGTGCTGCTGGAGAACTTCACCAGCGAGGCCGCCTTC ATCGAGAACCTGCGGCGGCGATTTCGGGAGAATCTCATCTACACCTACATTGGCCCCGTCCTGGTCTCTGTCAATCCCTACCGGGACCTG CAGATCTACAGCCGGCAGCATATGGAGCGTTACCGTGGCGTCAGCTTCTATGAAGTGCCCCCTCACCTGTTTGCCGTGGCGGACACTGTG TACCGAGCACTGCGCACGGAGCGTCGGGACCAGGCTGTGATGATCTCTGGGGAGAGCGGGGCAGGCAAGACCGAGGCCACCAAGAGGCTG CTGCAGTTCTATGCAGAGACCTGCCCAGCCCCCGAGCGCGGAGGTGCCGTGCGGGACCGGCTGCTACAGAGCAACCCGGTGCTGGAGGCC TTTGGAAATGCCAAGACCCTCCGGAACGATAACTCCAGCAGGTTCGGGAAGTACATGGATGTGCAGTTTGACTTCAAGGTGAAGAGCAGA ATAAAGAAGCGCTGCAGGACGTGGAAGACGAAAATCAGTGAGACATAAGCCAACAAGAGAAACCATCTCTGACCACCCCCTCCTCCCCAT CCCACCCTTTGGAAACTCCCCATTGTCACTGAGAACCACCAAATCTGACTTTTACATTTGGTCTCAGAATTTAGGTTCCTGCCCTGTTGG TTTTTTTTTTTTTTTTTTAAACAGTTTTCAAAAGTTCTTAAAGGCAAGAGTGAATTTCTGTGGATTTTACTGGTCCCAGCTTTTAGGTTC TTTAAGACACTAACAGGACTACATAGAGGCTTTTTCAGCATTACTGTGTCGTCTCCGTGCCAGATGTGGCAAGATCACCATTAGCAAATG GAAATTACATTTGAAAGCCATTAGACTTATAGGTGATGCAAGCATCTAAGAGAGAGGTTAATCACACTATAGAGGCATAAGTGGTATCAG TTTTCATTTTTCTAATTGTTTAAACTGTGTTTTATACCAGTGTTTGCAAGTAATTGGGTGTTAGCTTGAGATGGTTAAAGGTGGTTTGGG GAGGGACTTCGTTGTAATGGTTTTGCTGTAAAAAATGTTTCCAACTCCGCTGAAATGTTGCTGAAAAGCATGGTGCTGGTAACAGTTCAA CAATCCGTGGCTGCTCATTCTTGCCTACTTTACTCTCCCACTGAAGCAGGTTAGCGTTGAAGGTGGTATGGAAAAGCCTGCATGCCTGTT CAATTCTTTTGTTTCTTCTCCTTCCCCCTCCCCCTACCTCCTTCCCCTCACTCCTCCCCTCCTTCGCTCGCTCAACCTCTTTTGTTCAGT ATGTGTAACTTGAAGCTAATTTGTACTACTGGATATCTGACTGGAGCCACAGATACAGAATCTGTATTGTTCTTACTGAAACACAGCATG >In-frame_ENST00000545534_ENST00000571732_TCGA-94-8491_MYO1C_chr17_1385772_-_YWHAE_chr17_1248793_length(amino acids)=212AA_start in transcript=635_stop in transcript=0 MQQPLGGLGLACPALPRDHHSLVPTLRAQCSVHSVRHGKQVRGHFIEADATVTLHMLPAVDLQVPVGIDRDQDGANVGVDEILPKSPPQV LDEGGLAGEVLQQHEILHPHPVTGGERTLHGHPNPVTAQGHGKPSCLWVLLEGGGWCRLSKTLAPQPGLRWIPLQTGSQGSKKWTPRVSR -------------------------------------------------------------- >In-frame_ENST00000545534_ENST00000573026_TCGA-94-8491_MYO1C_chr17_1385772_-_YWHAE_chr17_1248793_length(transcript)=1443nt_BP=798nt GCCCCCGGCCAGAAATCTGGGCCTTTCGTGGTCAGAGGACACCGGCGGCCCCTTTGGGATCCACCCCCAATCACCACCACCTTGTTCTTC TCTGACCCTGGATACTCTGGGTGTCCATTTTTTGGAGCCCTGAGACCCTGTTTGAAGAGGGATCCATCTCAGCCCTGGTTGTGGGGCGAG GGTCTTGCTCAGCCTGCACCACCCTCCACCCTCCAGTAGGACCCAGAGGCAGCTGGGCTTTCCATGGCCCTGGGCAGTGACGGGGTTCGG GTGACCATGGAGAGTGCGCTCACCGCCCGTGACCGGGTGGGGGTGCAGGATTTCGTGCTGCTGGAGAACTTCACCAGCGAGGCCGCCTTC ATCGAGAACCTGCGGCGGCGATTTCGGGAGAATCTCATCTACACCTACATTGGCCCCGTCCTGGTCTCTGTCAATCCCTACCGGGACCTG CAGATCTACAGCCGGCAGCATATGGAGCGTTACCGTGGCGTCAGCTTCTATGAAGTGCCCCCTCACCTGTTTGCCGTGGCGGACACTGTG TACCGAGCACTGCGCACGGAGCGTCGGGACCAGGCTGTGATGATCTCTGGGGAGAGCGGGGCAGGCAAGACCGAGGCCACCAAGAGGCTG CTGCAGTTCTATGCAGAGACCTGCCCAGCCCCCGAGCGCGGAGGTGCCGTGCGGGACCGGCTGCTACAGAGCAACCCGGTGCTGGAGGCC TTTGGAAATGCCAAGACCCTCCGGAACGATAACTCCAGCAGGTTCGGGAAGTACATGGATGTGCAGTTTGACTTCAAGGTGAAGAGCAGA ATAAAGAAGCGCTGCAGGACGTGGAAGACGAAAATCAGTGAGACATAAGCCAACAAGAGAAACCATCTCTGACCACCCCCTCCTCCCCAT CCCACCCTTTGGAAACTCCCCATTGTCACTGAGAACCACCAAATCTGACTTTTACATTTGGTCTCAGAATTTAGGTTCCTGCCCTGTTGG TTTTTTTTTTTTTTTTTTAAACAGTTTTCAAAAGTTCTTAAAGGCAAGAGTGAATTTCTGTGGATTTTACTGGTCCCAGCTTTTAGGTTC TTTAAGACACTAACAGGACTACATAGAGGCTTTTTCAGCATTACTGTGTCGTCTCCGTGCCAGATGTGGCAAGATCACCATTAGCAAATG GAAATTACATTTGAAAGCCATTAGACTTATAGGTGATGCAAGCATCTAAGAGAGAGGTTAATCACACTATAGAGGCATAAGTGGTATCAG TTTTCATTTTTCTAATTGTTTAAACTGTGTTTTATACCAGTGTTTGCAAGTAATTGGGTGTTAGCTTGAGATGGTTAAAGGTGGTTTGGG GAGGGACTTCGTTGTAATGGTTTTGCTGTAAAAAATGTTTCCAACTCCGCTGAAATGTTGCTGAAAAGCATGGTGCTGGTAACAGTTCAA >In-frame_ENST00000545534_ENST00000573026_TCGA-94-8491_MYO1C_chr17_1385772_-_YWHAE_chr17_1248793_length(amino acids)=212AA_start in transcript=635_stop in transcript=0 MQQPLGGLGLACPALPRDHHSLVPTLRAQCSVHSVRHGKQVRGHFIEADATVTLHMLPAVDLQVPVGIDRDQDGANVGVDEILPKSPPQV LDEGGLAGEVLQQHEILHPHPVTGGERTLHGHPNPVTAQGHGKPSCLWVLLEGGGWCRLSKTLAPQPGLRWIPLQTGSQGSKKWTPRVSR -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for MYO1C-YWHAE |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for MYO1C-YWHAE |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for MYO1C-YWHAE |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | MYO1C | C0452138 | Sensorineural hearing loss, bilateral | 3 | CLINGEN |
Hgene | MYO1C | C1852282 | DEAFNESS, AUTOSOMAL DOMINANT 1 (disorder) | 3 | CLINGEN |
Hgene | MYO1C | C0004238 | Atrial Fibrillation | 1 | CTD_human |
Hgene | MYO1C | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
Hgene | MYO1C | C0235480 | Paroxysmal atrial fibrillation | 1 | CTD_human |
Hgene | MYO1C | C2585653 | Persistent atrial fibrillation | 1 | CTD_human |
Hgene | MYO1C | C3468561 | familial atrial fibrillation | 1 | CTD_human |
Tgene | YWHAE | C0036341 | Schizophrenia | 4 | PSYGENET |
Tgene | YWHAE | C0005586 | Bipolar Disorder | 2 | PSYGENET |
Tgene | YWHAE | C0206630 | Endometrial Stromal Sarcoma | 2 | ORPHANET |
Tgene | YWHAE | C0027627 | Neoplasm Metastasis | 1 | CTD_human |
Tgene | YWHAE | C0265219 | Miller Dieker syndrome | 1 | ORPHANET |
Tgene | YWHAE | C0334488 | Clear cell sarcoma of kidney | 1 | ORPHANET |
Tgene | YWHAE | C2750748 | Chromosome 17p13.3 Duplication Syndrome | 1 | ORPHANET |
Tgene | YWHAE | C4707092 | Distal 17p13.3 microdeletion syndrome | 1 | ORPHANET |